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Abstract: 
OBJECTIVE—To compare the odds of major depression among Medicare claimants with and 
without diabetes and to test whether annual medical payments are greater for those with both 
diabetes and major depression than for those with diabetes alone. 
RESEARCH DESIGN AND METHODS—This retrospective analysis relies on claims data from 
the 1997 Medicare 5% Standard Analytic Files. Using these data, we statistically determined 
whether the odds of major depression are greater among elderly claimants with diabetes after 
controlling for age, race/ethnicity, and sex. We then used regression analysis on a sample of over 
220,000 elderly claimants with diabetes to test whether payments for non-mental health-related 
services are greater for those with both diabetes and major depression (n = 4,203) than for those 
with diabetes alone. 
RESULTS—Our findings indicate that the odds of major depression are significantly greater 
among elderly Medicare claimants with diabetes than among those without diabetes (OR 1.58 ± 
0.05). We also found that elderly claimants with both diabetes and major depression seek 
treatment for more services and spend more time in inpatient facilities, and as a result incur 
higher medical costs than claimants with diabetes but without major depression. These results 
hold even after excluding services related to mental health treatment. 
CONCLUSIONS—This analysis suggests that treatment for major depression among claimants 
with diabetes may reduce total medical costs if treatment results in a decrease in utilization for 
general medical services in the future. 
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Article: 
Diabetes and major depression are two costly chronic conditions of which prevalence continues 
to increase among Medicare claimants. The percentage of Medicare claimants with evidence of 
diabetes increased 41% between 1992 and 2000 and now exceeds 13% of claimants (unpublished 
data from the Centers for Medicare and Medicaid Services). Due to either heightened awareness 
or increased prevalence, the percentage of Medicare claimants with at least one claim with a 
diagnosis of major depression in any given year has also increased and now exceeds 2% (1). 
Moreover, annual Medicare payments for those with diabetes average $9,580 per claimant (in 
1997 U.S. dollars), and annual payments for those with major depression average over $17,662 
(1). These figures compare with an average of $5,057 for those without these conditions (1). 
There are several reasons to suspect that the increasing prevalence rates of diabetes and major 
depression among Medicare claimants are related. It may be that individuals coping with any 
serious medical condition, including diabetes, are more likely to become clinically depressed. 
Because complications often increase with age, older individuals with diabetes may be even 
more likely to become depressed. It is also possible that the causality runs from depression to 
diabetes. Those with major depression may have less healthy diets and engage in limited 
physical activity, making them more susceptible to diabetes (2). This effect may also be 
attenuated with age. Major depression is also highly correlated with alcohol abuse, a presumed 
risk factor for diabetes (3). 
Anderson et al. (4) conducted a meta-analysis on 42 studies comparing the prevalence of major 
depression among individuals with and without diabetes. They report that the odds of major 
depression among those with diabetes are roughly twice that of those without diabetes. Although 
none of the included studies focused specifically on the elderly, their results suggest that the 
increased prevalence of diabetes among Medicare claimants could be at least partly responsible 
for the increased prevalence of major depression. 
Irrespective of causality, the costs associated with treating diabetes may be substantially greater 
for those with major depression. Major depression has been linked to hyperglycemia and poor 
blood glucose control (5), which may lead to physical complications that increase the cost of 
treating those with diabetes. DiMatteo, Lepper, and Croghan (6) note that individuals with major 
depression are less likely to follow prescribed treatment regimens. This noncompliance may take 
a variety of forms, including failure to follow dietary restrictions or take medication as indicated. 
Those with major depression are also more likely to abuse alcohol and drugs. Repercussions 
associated with each of these behaviors are more likely to occur later in life and may be 
especially evident among those with diabetes because of the adverse health consequences 
associated with noncompliance. 
We have identified only two papers that quantify the increase in costs for those with both 
diabetes and major depression compared with those with diabetes alone. Ciechanowski et al. (7) 
rely on a sample of several hundred individuals with diabetes in a single health plan and show 
that those with greater depressive symptoms have between 51 and 86% higher costs. Egede et al. 
(8) use data from 825 individuals with diabetes who participated in the Medical Expenditure 
Panel Survey (MEPS) (85 of which report having major depression) and show that those with 
both major depression and diabetes have 4.5 times greater annual health care expenditures than 
those with diabetes alone. Both studies rely on small samples and self-reported data, and neither 
focuses specifically on the elderly. Moreover, these studies compare total costs, which include 
the costs for mental health treatment. Regardless of whether major depression adversely affects 
an individual’s physical health, total costs are expected to be higher for those with major 
depression due to the costs associated with mental health treatment. 
In this analysis, we rely on an extremely large sample of nationally representative Medicare 
claimants to test whether the odds of having major depression are greater among elderly 
claimants with diabetes than among those without diabetes (1) and whether annual payments for 
general medical services (i.e., non-mental health-related services) are greater for those with both 
diabetes and major depression than for those with diabetes alone (2), suggesting that major 
depression adversely affects both the mental and physical health of elderly Medicare claimants. 
We then explored the causes of payment differences between the two groups. 
RESEARCH DESIGN AND METHODS 
Data 
We used data from the 1997 Medicare 5% Standard Analytic Files (SAF), which include data for 
all covered services for over 2 million Medicare claimants. Because our focus is on the elderly, 
we limit the sample to claimants aged 65 and older. We also exclude claimants who at any point 
in the year were enrolled in a Medicare health maintenance organization or who did not have 
complete coverage for both physician and hospital services for all 12 months. These exclusions 
ensure that we have complete claims for the remaining 1.3 million claimants eligible to be 
included in the analyses. 
Methods 
Based on the diagnosis codes recorded on each claim, we identified three subsamples from the 
Medicare 5% files: claimants with evidence of diabetes and no evidence of major depression, 
claimants with evidence of major depression and no evidence of diabetes, and claimants with 
evidence of both diabetes and major depression. 
Based on the algorithm presented by Hebert et al. (9), the following diagnosis codes are used to 
identify diabetes: 
 250: Diabetes Mellitus
 357.2: Neuropathy in Diabetes
 362.01: Diabetic Retinopathy NOS
 362.02: Proliferative Diabetic Retinopathy
 366.41: Diabetic Cataract
Claimants with at least one of the included codes for diabetes on any claim, whether as a primary 
or secondary diagnosis, are assumed to have diabetes. Similarly, we identify major depression by 
International Classification of Diseases (ICD)-9 diagnosis codes 296.2 and 296.3, which define 
either single or multiple episodes of major depressive disorder. 
We computed the diagnosed annual prevalence of major depression among claimants with 
diabetes by determining the percentage of claimants with diabetes with at least one diagnosis for 
major depression. We similarly compute the diagnosed annual prevalence of major depression 
among claimants without diabetes by determining the percentage of all claimants without 
diabetes with at least one diagnosis for major depression. We then use a Cochran-Mantel 
Haenszel χ2 test to statistically determine whether the odds of major depression are greater 
among elderly claimants with diabetes after controlling for age, race/ethnicity, and sex. For a 
variety of reasons (e.g., misclassification and underreporting), the diagnosed annual prevalence 
rates are likely to be biased downward; however, as long as the bias is similar among those with 
and without diabetes, then the ratio of these rates represents an unbiased estimate of the odds of 
major depression among those with and without diabetes. 
Total annual payments, which include Medicare payments, individual co-payments, and other 
third-party payments, for claimants with both diabetes and major depression are expected to be 
higher solely because of payments for services associated with treating the mental health 
condition. To account for this, the cost analysis focuses solely on payments for non-mental 
health-related services. Each claim is determined to be mental health related or non-mental 
health related based on the primary diagnosis on the claim. 
Because differences in payments may be because of differences between samples, aside from the 
presence or absence of major depression, we compute payment differences via the following 
ordinary least squares (OLS) regression equation: 
where MD represents an indicator variable for major depression, and X represents a vector of 
variables indicating the presence of select comorbid conditions and demographic characteristics. 
We include three separate measures of payment: total annual payments for all non-mental health-
related services, total annual payments for non-mental health-related physician services, and total 
annual payments for non-mental health-related inpatient services. 
The comorbid conditions are a slightly condensed version of the set of comorbidity measures 
recommended for use with administrative data by Elixhauser et al. (10). Because everyone in the 
sample has positive annual payments by construction (i.e., they all have at least one claim 
indicating diabetes), and a small percentage of individuals have extremely large payments, the 
regressions are estimated using the natural logarithm of annual payments to minimize the 
undesirable skewness in the expenditure distribution (11). This approach minimizes the 
undesirable skewness in the expenditure distribution and also allows us to interpret the 
coefficients as the percentage change in payments associated with a one unit increase in each 
independent variable. [The actual percentage change is equal to exp(β) − 1, which is roughly 
equal to β when β is small.] 
The coefficient on the major depression variable, β1, measures the percentage change in average 
annual non-mental health-related payments for claimants with both diabetes and major 
depression compared with claimants with diabetes alone, after controlling for other demographic 
and comorbid conditions that might affect payments. Because major depression may be at least 
partly responsible for the presence of the comorbid conditions, we ran the regressions both 
including and excluding these variables. 
Finally, because of differences uncovered in the initial regressions, we included three additional 
regressions, each with the same set of independent variables. The first is an OLS regression that 
uses the total number of non-mental health-related physician services received as the dependent 
variable. The second focuses on the probability of a non-mental health-related inpatient visit and 
is estimated using a logistic regression. The third is a negative binomial regression that uses the 
total number of non-mental health-related inpatient days as the dependent variable and is 
restricted to those individuals who had an inpatient visit. The negative binomial model is 
appropriate for count data models of this sort (12). 
The first specification allows for assessing whether individuals with both diabetes and major 
depression have more non-mental health-related physician services than those with diabetes 
alone. The second and third specifications allow for assessing (1) whether those with both 
diabetes and major depression are more likely to have an inpatient visit and (2), if admitted, 
whether their length of stay is likely to be longer than those with diabetes alone. 
RESULTS 
Table 1 presents mean and median payments for non-mental health-related services, and 
demographic characteristics and comorbid conditions associated with the three subgroups. As 
shown in the table, mean payments are roughly twice as great and median payments are over 
three times greater for those with both diabetes and major depression. Although there are not 
major differences in average age or race, there are other differences that may be at least partly 
responsible for the payment differentials. Claimants with diabetes and major depression have, on 
average, more comorbidities than those in the other two subgroups, and they consistently have 
the highest rates for all of the included comorbidities. 
The diagnosed annual prevalence of major depression among claimants with diabetes is 2.85% 
compared with 1.88% among claimants without diabetes (Table 2). The corresponding OR 
suggests that elderly claimants with diabetes are 1.58 times more likely to have major 
depression. A Cochran-Mantel Haenszel χ2 test (not reported) reveals that this difference is 
statistically significant after controlling for age, race/ethnicity, and sex (P < 0.0001). 
In fact, major depression is consistently higher among claimants with diabetes than among 
claimants without diabetes in select age, race/ethnicity, and sex strata. Results also reveal that 
major depression is more common among women than men and Hispanics than whites, blacks, 
or claimants of other races, and the diagnosed annual prevalence rate of major depression 
increases with age. 
In fact, major depression is consistently higher among claimants with diabetes than among 
claimants without diabetes in select age, race/ethnicity, and sex strata. Results also reveal that 
major depression is more common among women than men and Hispanics than whites, blacks, 
or claimants of other races, and the diagnosed annual prevalence rate of major depression 
increases with age. 
Model 1 in Table 3 shows the regression results for non-mental health-related total payments. 
The coefficient associated with major depression (0.19) suggests that claimants with diabetes 
who also have major depression are associated with 21% ([exp(0.19) − 1]*100 = 21%) greater 
annual non-mental health-related payments. The coefficient increases to 1.13 when the 
comorbidity variables are excluded (results not reported); however, the fit of the model is 
reduced substantially with the exclusion of these variables, making these results suspect. The 
regression also reveals that a 1-year increase in age is associated with an average 3% increase in 
payments. Men are associated with larger payments, as are Hispanics and those whose initial 
reason for eligibility is not “age.” As expected, all of the comorbidities positively impact 
payments. 
The second specification focuses specifically on non-mental health-related payments for 
physician services. Among claimants with diabetes, major depression is associated with 23% 
greater payments for non-mental health-related physician services. 
Model 3 focuses specifically on the total number of non-mental health-related physician services 
provided. Claimants with diabetes and major depression experienced an average of 14 additional 
non-mental health-related physician services in 1997. To put this result into perspective, a 65-
year-old white female claimant with diabetes who aged into the system and had no evidence of 
the included comorbidities received ∼12 non-mental health-related physician services; this 
number jumps to 26 if there is also evidence of major depression. Table 4 presents results of the 
inpatient regressions. The statistically insignificant coefficient on the major depression variable 
in model 4 suggests that claimants with both diabetes and major depression are no more likely to 
have an inpatient non-mental health-related visit than claimants with diabetes without major 
depression. Model 5 includes only those claimants who had at least one inpatient non-mental 
health-related stay in 1997. The major depression coefficient reveals that total payments increase 
by 7% if the claimant also has evidence of major depression. 
The final model in Table 4 offers one explanation for the additional inpatient payments. The 
dependent variable in this regression is annual non-mental health-related inpatient days. Those 
with major depression have an average of 17% more non-mental health-related inpatient days. 
CONCLUSIONS 
Results indicate that the odds of major depression are roughly 1.6 times greater among elderly 
Medicare claimants with diabetes than among those without diabetes. In deriving this estimate, 
we assume that the probability that a person with major depression has a claim indicating this 
diagnosis is the same regardless of whether the claimant has diabetes. However, claimants with 
diabetes have substantially more contact with the health care system, which may increase the 
likelihood of a diagnosis of major depression. Under this scenario, the OR would be biased 
upward. However, our estimate is actually smaller than that reported by Anderson et al. (4). 
We also test whether claimants with both diabetes and major depression are associated with 
greater non-mental health-related payments than claimants with diabetes without evidence of 
major depression. Unlike previous studies, we focus on payments for non-mental health-related 
services because these services are more likely to be associated with diabetes and are less likely 
to be associated with treatment for major depression. 
We find that claimants with both diabetes and major depression have greater costs and utilization 
than claimants with diabetes without major depression. They seek treatment for more services, 
and, when admitted, spend more time in inpatient facilities than claimants with diabetes without 
major depression. We also find that both the diagnosed annual prevalence of major depression 
and payments vary systematically by race/ethnicity. Hispanics had the highest rates of major 
depression, and blacks had the lowest rates. Hispanics were also associated with higher non-
mental health-related payments than whites, and blacks were associated with lower payments. 
The motivation behind these differences is unclear. 
 
Although Medicare data allow us to construct nationally representative estimates, we are limited 
to the information available on the Medicare claims data. Therefore, we cannot assess the causal 
relationship between diabetes and depression, nor can we identify individuals with diabetes 
and/or major depression who do not have a claim for these conditions. Because of the stigma and 
historically low reimbursement rates associated with mental illness, it is likely that the 
underreporting of major depression is greater than that of other health conditions. Additionally, a 
significant portion of health care utilization and costs for Medicare eligible claimants does not 
generate a Medicare claim under any circumstances (e.g., prescription drugs and other 
noncovered services); therefore, that information is not included in this analysis. We are also 
unable to compare long-term outcomes or costs for those who receive treatment for major 
depression with those who do not. 
 
Even with these limitations, the results of this study are important. This analysis suggests a 
possible link between major depression and diabetes and that treatment for major depression may 
actually reduce costs if treatment results in a decrease in utilization for general medical services 
in the future. An obvious next step is to use panel data to try to assess the causal relationship 
between diabetes and depression and to compare long-term costs between claimants with both 
diabetes and major depression who do or do not receive mental health treatment. Future research 
should also focus on understanding racial and ethnic differences in the prevalence and costs of 
both major depression and diabetes. 
 
ACKNOWLEDGEMENTS 
 
Funding for this work was provided by the Substance Abuse and Mental Health Services 
Administration (SAMHSA) under contract number 280-99-0701. The views expressed in this 
paper are not necessarily those of SAMHSA or RTI. 
 
The authors thank Susan Murchie for editorial review. 
 
REFERENCES 
 
1. The MEDSTAT Group: Round Two Analytic Tables. Prepared for the Substance Abuse and 
Mental Health Services Administration under contract no. 280-95-0011, December 2000 
 
2. Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE: Depression and risk for onset of type II 
diabetes: a prospective population-based study. Diabetes Care 19 : 1097 –1102,1996 
 
3. Kao WH, Puddey IB, Boland LL, Watson RL, Brancati FL: Alcohol consumption and the risk 
of type 2 diabetes mellitus: atherosclerosis risk in communities study. Am J Epidemiol 154 : 748 
–757, 2001 
4. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ: The prevalence of comorbid depression 
in adults with diabetes. Diabetes Care 24 : 1069 –1078, 2001 
 
5. Lustman PJ, Anderson RJ, Freedland KE, DeGroot M, Carney RM, Clouse RE: Depression 
and poor glycemic control. Diabetes Care 23 : 934 –942, 2000 
 
6. DiMatteo MR, Lepper HS, Croghan TW: Depression is a risk factor for noncompliance with 
medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. 
Arch Intern Med 160 : 2101 –2107, 2000 
 
7. Ciechanowski PS, Katon WJ, Russo JE: Depression and diabetes: impact of depressive 
symptoms on adherence, function, and costs. Arch Intern Med 160 : 3278 –3285, 2000 
 
8. Egede LE, Zheng D, Simpson K: Comorbid depression is associated with increased health 
care use and expenditures in individuals with diabetes. Diabetes Care 25 : 464 –470, 2002 
 
9. Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM: Identifying persons 
with diabetes using Medicare claims data. Am J Med Qual 14 : 270 –277, 1999 
 
10. Elixhauser A, Steiner C, Harris DR, Coffey RM: Comorbidity measures for use with 
administrative data. Med Care 36 : 8 –27, 1998 
 
11. Manning W, Newhouse J, Duan N, Keeler E, Leibowitz A, Marquis S: Health insurance and 
the demand for medical care: evidence from a randomized experiment. Am Econ Rev 77 : 251 –
277, 1987 
 
12. Jones A: Health economics. In Handbook of Health Economics. Vol. 1A . Culyer AJ, 
Newhouse JP, Eds. Amsterdam, North Holland Press, 2000 
